Adherens junctions, desmosomes and tight junctions in epidermal barrier function

Open Dermatology Journal

Volumn 4, Issue 1, 2010, Pages 14-20

  Brandner, Johanna M ^a   Haftek, Marek ^b   Niessen, Carien M ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cadherins; Catenins; Cell polarity; Claudins; Skin diseases; Stratum corneum

Indexed keywords

CADHERIN; DESMOCOLLIN; DESMOGLEIN 1; P CADHERIN; UVOMORULIN;

ARTICLE; CELL JUNCTION; DESMOSOME; EPIDERMIS; HUMAN; KERATINOCYTE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SKIN FUNCTION; SKIN PERMEABILITY; STRUCTURE ANALYSIS; TIGHT JUNCTION;

EID: 77953778869     PISSN: None     EISSN: 18743722     Source Type: Journal    
DOI: 10.2174/1874372201004010014     Document Type: Article

References (49)

1. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2009; 124: R2-6.
2. Perez-Moreno M, Fuchs E. Catenins: keeping cells from getting their signals crossed. Dev Cell 2006; 11: 601-12.
3. Evangelista F, Dasher DA, Diaz LA, Prisayanh PS, Li N. E-cadherin is an additional immunological target for pemphigus autoantibodies. J Invest Dermatol 2008; 128: 1710-8.
4. Tinkle CL, Lechler T, Pasolli HA, Fuchs E. Conditional targeting of E-cadherin in skin: insights into hyperproliferative and degenerative responses. Proc Natl Acad Sci USA 2004; 101: 552-7.
5. Young P, Boussadia O, Halfter H, et al. E-cadherin controls adherens junctions in the epidermis and the renewal of hair follicles. EMBO J 2003; 22: 5723-33.
6. Tunggal JA, Helfrich I, Schmitz A, et al. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J 2005; 24: 1146-56.
7. Radice GL, Ferreira-Cornwell MC, Robinson SD, et al. Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol 1997; 139: 1025-32.
8. Sprecher E, Bergman R, Richard G, et al. Hypotrichosis with juvenile macular dystrophy is caused by a mutation in CDH3, encoding P-cadherin. Nat Genet 2001; 29: 134-6.
9. Kjaer KW, Hansen L, Schwabe GC, et al. Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome). J Med Genet 2005; 42: 292-8.
10. Perez-Moreno M, Davis MA, Wong E, Pasolli HA, Reynolds AB, Fuchs E. p120-catenin mediates inflammatory responses in the skin. Cell 2006; 124: 631-44.
11. Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell 2001; 104: 605-17.
12. Tinkle CL, Pasolli HA, Stokes N, Fuchs E. New insights into cadherin function in epidermal sheet formation and maintenance of tissue integrity. Proc Natl Acad Sci USA 2008; 105: 15405-10.
13. Michels C, Buchta T, Bloch W, Krieg T, Niessen CM. Classical cadherins regulate desmosome formation. J Invest Dermatol 2009; 129: 2072-5.
14. Kowalczyk AP, Bornslaeger EA, Norvell SM, Palka HL, Green KJ. Desmosomes: intercellular adhesive junctions specialized for attachment of intermediate filaments. Int Rev Cytol 1999; 185: 237-302.
15. McMillan JR, Haftek M, Akiyama M, et al. Alterations in desmosome size and number coincide with the loss of keratinocyte cohesion in skin with homozygous and heterozygous defects in the desmosomal protein plakophilin 1. J Invest Dermatol 2003; 121: 96-103.
16. Ayub M, Basit S, Jelani M, et al. A homozygous nonsense mutation in the human desmocollin-3 (DSC3) gene underlies hereditary hypotrichosis and recurrent skin vesicles. Am J Hum Genet 2009; 85: 515-20.
17. Cirillo N, Prime SS. Desmosomal interactome in keratinocytes: a systems biology approach leading to an understanding of the pathogenesis of skin disease. Cell Mol Life Sci 2009; 66: 3517-33.
18. Nguyen B, Dusek RL, Beaudry VG, Marinkovich MP, Attardi LD. Loss of the desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris autoantibodies. J Invest Dermatol 2009; 129: 1710-8.
19. Egelrud T, Hofer PA, Lundstrom A. Proteolytic degradation of desmosomes in plantar stratum corneum leads to cell dissociation in vitro. Acta Derm Venereol 1988; 68: 93-7.
20. Simon M, Jonca N, Guerrin M, et al. Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem 2001; 276: 20292-9.
21. Haftek M, Callejon S, Sandjeu Y, et al. Tight junction-like structures contribute to the lateral contacts between corneocytes and protect corneodesmosomes from premature degradation. J Invest Dermatol 2009; 129: S65.
22. Jonca N, Guerrin M, Hadjiolova K, et al. Corneodesmosin, a component of epidermal corneocyte desmosomes, displays homophilic adhesive properties. J Biol Chem 2002; 277: 5024-9.
23. Haftek M, Simon M, Kanitakis J, et al. Expression of corneodesmosin in the granular layer and stratum corneum of normal and diseased epidermis. Br J Dermatol 1997; 137: 864-73.
24. Lundstrom A, Serre G, Haftek M, Egelrud T. Evidence for a role of corneodesmosin, a protein which may serve to modify desmosomes during cornification, in stratum corneum cell cohesion and desquamation. Arch Dermatol Res 1994; 286: 369-75.
25. Haftek M, Serre G, Mils V, Thivolet J. Immunocytochemical evidence for a possible role of cross-linked keratinocyte envelopes in stratum corneum cohesion. J Histochem Cytochem 1991; 39: 1531-8.
26. Ovaere P, Lippens S, Vandenabeele P, Declercq W. The emerging roles of serine protease cascades in the epidermis. Trends Biochem Sci 2009; 34: 453-63.
27. Walsh A, Chapman SJ. Sugars protect desmosome and corneosome glycoproteins from proteolysis. Arch Dermatol Res 1991; 283: 174-9.
28. Haftek M, Teillon MH, Schmitt D. Stratum corneum, corneodesmosomes and ex vivo percutaneous penetration. Microsc Res Tech 1998; 43: 242-9.
29. Leclerc EA, Huchenq A, Mattiuzzo NR, et al. Corneodesmosin gene ablation induces lethal skin-barrier disruption and hair-follicle degeneration related to desmosome dysfunction. J Cell Sci 2009; 122: 2699-709.
30. Brandner JM, Kief S, Grund C, et al. Organization and formation of the tight junction system in human epidermis and cultured keratinocytes. Eur J Cell Biol 2002; 81: 253-63.
31. Furuse M, Hata M, Furuse K, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002; 156: 1099-111.
32. Brandner JM. Tight junctions and tight junction proteins in mammalian epidermis. Eur J Pharm Biopharm 2009; 72: 289-94.
33. Elias PM, Friend DS. The permeability barrier in mammalian epidermis. J Cell Biol 1975; 65: 180-91.
34. Logan KR, Hopwood D, Milne G. Cellular junctions in human oesophageal epithelium. J Pathol 1978; 126: 157-63.
35. Elias PM, McNutt NS, Friend DS. Membrane alterations during cornification of mammalian squamous epithelia: a freeze-fracture, tracer, and thin-section study. Anat Rec 1977; 189: 577-94.
36. Furuse M, Hata M, Furuse K, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002; 156: 1099-111.
37. Helfrich I, Schmitz A, Zigrino P, et al. Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier formation. J Invest Dermatol 2007; 127: 782-91.
38. Mertens AE, Rygiel TP, Olivo C, van der Kammen R, Collard JG. The Rac activator Tiam1 controls tight junction biogenesis in keratinocytes through binding to and activation of the Par polarity complex. J Cell Biol 2005; 170: 1029-37.
39. Yuki T, Haratake A, Koishikawa H, Morita K, Miyachi Y, Inoue S. Tight junction proteins in keratinocytes: localization and contribution to barrier function. Exp Dermatol 2007; 16: 324-30.
40. Brandner JM, Kief S, Wladykowski E, Houdek P, Moll I. Tight junction proteins in the skin. Skin Pharmacol Physiol 2006; 19: 71-7.
41. Kirschner N, Poetzl C, von den Driesch P, et al. Alteration of tight junction proteins is an early event in psoriasis: putative involvement of proinflammatory cytokines. Am J Pathol 2009; 175: 1095-106.
42. Pummi K, Malminen M, Aho H, Karvonen S-L, Peltonen J, Peltonen S. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol 2001; 117: 1050-58.
43. Watson RE, Poddar R, Walker JM, et al. Altered claudin expression is a feature of chronic plaque psoriasis. J Pathol 2007; 212: 450-8.
44. Yoshida Y, Morita K, Mizoguchi A, Ide C, Miyachi Y. Altered expression of occludin and tight junction formation in psoriasis. Arch Dermatol Res 2001; 293: 239-44.
45. Gumbiner B, Stevenson B, Grimaldi A. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 1988; 107: 1575-87.
46. Suzuki A, Yamanaka T, Hirose T, et al. Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J Cell Biol 2001; 152: 1183-96.
47. Turksen K, Troy TC. Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development 2002; 129: 1775-84.
48. Leyvraz C, Charles RP, Rubera I, et al. The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol 2005; 170: 487-96.
49. Gareus R, Huth M, Breiden B, et al. Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation. Nat Cell Biol 2007; 9: 461-9.